by CheckRare Staff | Feb 23, 2026
Sophia Ceulemans, MS, Medical Science Liaison at GeneDx offered a high-level overview of the problem of unexplained epilepsy and the rapidly advancing field of genetic testing for this challenging disorder. Ms. Ceulemans co-authored the current guidelines from the...
by CheckRare Staff | Feb 20, 2026
PRIMA Clinical Trial Bradley J. Monk, MD, Medical Director, Florida Cancer Specialists and Research Institute, West Palm Beach, and Founder of GOG Partners, discusses the clinical advances in the treatment of ovarian cancer, including research using PARP inhibitors,...
by CheckRare Staff | Feb 2, 2026
Neuroblastoma is a rare childhood cancer, but it is the most common extracranial solid tumor in children. It is a neuroendocrine tumor that originates in neuroblasts or neural crest progenitor cells. It often appears initially in the adrenal glands, but tumors can be...
by CheckRare Staff | Nov 15, 2025
Philip Molyneaux, MD, PhD, a Professor of Interstitial Lung Disease (ILD) at Imperial College London and the Asthma+Lung UK Chair of Respiratory Research at Royal Brompton Hospital, where is also the Director of the UK National Institute for Health and Care Research...
by CheckRare Staff | Oct 29, 2025
Accurate diagnosis and treatment of epilepsy challenges the medical community, patients, and their loved ones.[1] As many as one third of patients have seizures that are inadequately controlled with available therapies, and treatment response is highly variable.[2,3]...
